Skip to main content
. 2012 Dec 27;12:377. doi: 10.1186/1471-2334-12-377

Table 2.

Reasons for discontinuation of treatment

Reasons for discontinuation Number of patients,n (%)
Adverse Events
40 (18.5)
No reduction of 2 log viral load at week 12
3 (1.4)
Positive PCR qualitative at week 24
5 (2.3)
Withdrawal of the patients
3 (1.4)
Total discontinuation of treatment 51 (23.6)